Seraphina Therapeutics Announces C15:0, an Essential Fatty Acid, Reverses Key Components of Cellular Fragility Syndrome in a Second, Independent Model
New study further supports the role of C15:0 in preventing and reversing the alarming rise in liver disease. A new independent study has revalidated the use of C15:0 to reverse core components of a newly discovered nutritional C15:0 deficiency syndrome, called Cellular Fragility Syndrome, which may be impacting as many as 1 in 3 people […]